<span item_type="fundamental" item_id="dea9d4e4346bff72b043667280b47453" counter_id="ST/US/CYCA" env="prod"></span><span item_type="announcement" item_id="566494417416423041" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 1.249 K.</p><p>EPS: As of FY2025 Q2, the actual value is USD 0.01.</p><p>EBIT: As of FY2025 Q2, the actual value is USD -506.37 K.</p><p></p><h3>Segment Revenue</h3><ul><li>Revenues for the three and six months ended March 31, 2025, were $1,249 and $2,498, respectively, compared to $0 and $2,411 for the same periods in 2024. These revenues were from deferred revenue on subscription agreements being recognized.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income (Loss):</strong> For the three months ended March 31, 2025, net income was $6,221,800, compared to a net loss of $988,541 for the same period in 2024. For the six months ended March 31, 2025, net income was $5,497,681, compared to a net loss of $2,047,669 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li><li><strong>Operating Expenses:</strong> Operating expenses were $562,035 and $1,204,241 for the three and six months ended March 31, 2025, compared to $905,710 and $1,896,162 for the same periods in 2024, showing a decrease of $343,675 and $691,921, respectively.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Operating Cash Flow:</strong> Net cash used in operating activities was $807,774 for the six months ended March 31, 2025, compared to $790,660 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li><li><strong>Investing Cash Flow:</strong> The company purchased $3,000 of property and equipment during the six months ended March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li><li><strong>Financing Cash Flow:</strong> There were no financing activities for the six months ended March 31, 2025, compared to $557,500 received from convertible promissory notes in the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Unrealized Gain on Marketable Securities:</strong> The company recorded an unrealized gain of $7,661,898 on the fair value change of marketable securities for the three and six months ended March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus:</strong> The company is working to finalize the MMP (Minimum Marketable Product) version of the CyttaCOMMS software designated CyttaCOMMS 2.0 for the marketplace. This product is expected to enhance real-time video and audio situational awareness for various emergency services.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li><li><strong>Non-Core Business:</strong> The company is also focusing on the CyttaCARES system, which is in the trial stage and requires additional work to reach the MMP stage before live demonstrations in schools can begin.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li></ul><h3>Priority</h3><ul><li>The company emphasizes the development and market introduction of CyttaCOMMS 2.0 and CyttaCARES as strategic priorities, with a focus on enhancing safety and security solutions in educational institutions and emergency response scenarios.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1383088/000147793225007262/cyca_10q.htm"></span></li></ul>

Cytta Corp. | 10-Q: FY2025 Q2 Revenue: USD 1.249 K